Erosive Esophagitis: Developing Drugs for Treatment Draft Guidance for Industry September 2025 +++

September 16, 2025 Draft Guidance: Disseminated Coccidioidomycosis: Developing Drugs for Treatment Disseminated Coccidioidomycosis: Developing Drugs for Treatment Draft Guidance for Industry September 2025 https://www.fda.gov/regulatory-information/search-fda-guidance-documents/disseminated-coccidioidomycosis-developing-drugs-treatment Draft Guidance: Symptomatic Nonerosive Gastroesophageal Reflux Disease: Developing Drugs for Treatment Symptomatic Nonerosive Gastroesophageal Reflux Disease: Developing Drugs for Treatment Draft Guidance for Industry September 2025 https://www.fda.gov/regulatory-information/search-fda-guidance-documents/symptomatic-nonerosive-gastroesophageal-reflux-disease-developing-drugs-treatment Draft Guidance: Erosive Esophagitis: Developing Drugs for Treatment Erosive Esophagitis: Developing Drugs for Treatment Draft Guidance for Industry September 2025 https://www.fda.gov/regulatory-information/search-fda-guidance-documents/erosive-esophagitis-developing-drugs-treatment